Potential Prescription Omission

Potential prescription omission differed strongly by healthcare setting, with higher prevalence in inpatient studies than outpatient studies. Potential prescription omission was lower than other reviewed medication-safety outcomes but remained clinically important. Potential prescription omission refers to failure to prescribe a clinically indicated medication for treatment or prevention. The paper does not analyze standard PPO with a separate value network. Extending the analysis to PPO is identified as future work. The pooled prevalence of potential prescription omission was 14%. Potential prescription omission prevalence was significantly associated with publication year in meta-regression. A positive PPO result would generalize DGG-style interventions to actor-critic RLVR systems.